Clinical Clarity

One Molecule at a Time

Single Molecule Counting (SMC™) from Singulex is transforming clinical diagnostics and scientific discovery.

Learn More

Clinical Lab Testing Services
Clinical Diagnostics System

Singulex is the developer and leading provider of single molecule counting (SMCTM) technology for clinical diagnostics and scientific discovery. Singulex's proprietary SMC technology enables physicians and scientists to detect biomarkers of disease that were previously undetectable. Powered by SMC technology, Singulex's ultra-sensitive immunoassay solutions and lab testing services are transforming patient care from reactive disease treatment to proactive health management and fueling the discovery and development of new therapeutics.

Press Releases

  • May 21, 2015
    Singulex Announces EMD Millipore to Acquire Exclusive Rights to Singulex’s Ultra-Sensitive Single Molecule Counting (SMCTM) Technology
  • April 30, 2015
    Singulex Announces Partnership with The Dutch Technology Foundation (STW) to Accelerate the Development of Clinical Biomarkers

Upcoming Events

  • May 30, 2015 - May 31, 2015:
    AzNMA Spring Arizona Naturopathic Medical Association Medical Conf
    Exhibit Booth #36 Scottsdale, AZ
  • Jun 2, 2015 - Jun 3, 2015:
    Merck Technology Sympoisum
    Exhibit: Booth # 615 Somerset, NJ